StockData
Standard BioTools Inc. logo

Standard BioTools Inc. (LAB) stock

LABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 12/3087% below fair value
$0.57+0.03 (+5.67%)

Close on Nov 18, 2026Market cap $223.77MP/E 2.6Yield –

Standard BioTools free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Standard BioTools's free cash flow for the twelve months ending Jun 30, 2026 was -$82.58M. For fiscal 2025 it was -$82.65M. The highest annual figure on record is -$5.04M in fiscal 2013.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$82.65M–
FY2024Dec 31, 2024-$151.81M–
FY2023Dec 31, 2023-$46.12M–
FY2022Dec 31, 2022-$93.20M–
FY2021Dec 31, 2021-$57.33M–
FY2020Dec 31, 2020-$28.13M–
FY2019Dec 31, 2019-$37.74M–
FY2018Dec 31, 2018-$25.57M–
FY2017Dec 31, 2017-$25.66M–
FY2016Dec 31, 2016-$44.20M–
FY2015Dec 31, 2015-$38.72M–
FY2014Dec 31, 2014-$30.03M–
FY2013Dec 31, 2013-$5.04M–
FY2012Dec 31, 2012-$19.86M–
FY2011Dec 31, 2011-$19.22M–
FY2010Dec 31, 2010-$13.05M–
FY2009Dec 31, 2009-$20.31M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$10.66M–
Q1 FY2026Mar 31, 2026-$47.17M–
Q4 FY2025Dec 31, 2025-$1.67M–
Q3 FY2025Sep 30, 2025-$23.09M–
Q2 FY2025Jun 30, 2025-$22.56M–
Q1 FY2025Mar 31, 2025-$35.34M–
Q4 FY2024Dec 31, 2024-$17.44M–
Q3 FY2024Sep 30, 2024-$30.12M–
Q2 FY2024Jun 30, 2024-$40.99M–
Q1 FY2024Mar 31, 2024-$63.26M–
Q4 FY2023Dec 31, 2023-$14.14M–
Q3 FY2023Sep 30, 2023-$12.32M–
Q2 FY2023Jun 30, 2023-$10.17M–
Q1 FY2023Mar 31, 2023-$9.50M–
Q4 FY2022Dec 31, 2022-$19.94M–
Q3 FY2022Sep 30, 2022-$25.88M–
Q2 FY2022Jun 30, 2022-$30.93M–
Q1 FY2022Mar 31, 2022-$16.46M–
Q4 FY2021Dec 31, 2021-$7.47M–
Q3 FY2021Sep 30, 2021-$11.20M–
Q2 FY2021Jun 30, 2021-$18.84M–
Q1 FY2021Mar 31, 2021-$19.82M–
Q4 FY2020Dec 31, 2020-$14.44M–
Q3 FY2020Sep 30, 2020-$4.94M–
Q2 FY2020Jun 30, 2020-$3.43M–
Q1 FY2020Mar 31, 2020-$5.33M–
Q4 FY2019Dec 31, 2019-$6.02M–
Q3 FY2019Sep 30, 2019-$5.89M–
Q2 FY2019Jun 30, 2019-$5.43M–
Q1 FY2019Mar 31, 2019-$20.40M–
Q4 FY2018Dec 31, 2018-$658.00K-236.2%
Q3 FY2018Sep 30, 2018-$4.26M–
Q2 FY2018Jun 30, 2018-$4.40M–
Q1 FY2018Mar 31, 2018-$16.25M–
Q4 FY2017Dec 31, 2017$483.00K–
Q3 FY2017Sep 30, 2017-$8.54M–
Q2 FY2017Jun 30, 2017-$8.43M–
Q1 FY2017Mar 31, 2017-$9.18M–
Q4 FY2016Dec 31, 2016-$11.42M–
Q3 FY2016Sep 30, 2016-$14.97M–

More Standard BioTools figures

See a number that looks wrong?